K-beauty tech revolution more than skin-deep


SEOUL: South Korean beauty devices have been shifting gears, easing their way into global skin care routines and learning, along the way, to do more.

South Korea’s exports of at-home beauty devices hit a record US$212.2mil in 2024, nearly doubling from the year prior. Momentum continued into 2025, with exports jumping 42% on-year in the first half.

Analysts at KPMG Korea trace the trend to the meeting point of proactive ageing care and new technologies that deliver effective results. The beauty device market is projected to surge from US$14bil in 2022 to US$89.8bil by 2030, according to local accounting firm Samil PwC.

At the forefront of South Korea’s beauty tech surge is APR, whose Medicube AGE-R line has become a breakout success in the global beauty device market.

Since debuting its beauty device products in 2021, APR has sold over five million devices worldwide, with two million units sold in just the first nine months of this year alone. The device segment recorded 103.1 billion won in third-quarter revenue, up 39% on-year, contributing to total revenue of 385.9 billion won.

Industry analysts viewed APR’s integrated ecosystem, combining devices, skin care and mobile applications, as central to its evolution into a next-generation platform, particularly in global markets.

Overseas markets generated more than 80% of total revenue in the third quarter, exceeding 300 billion won, while the United States accounted for 39% of sales.

The strategy proved effective in Japan, where the company built a loyal following amid strong competition from established names such as Panasonic Beauty and Ya-Man.

“One way we stand out is by combining skin care and devices to make effective at-home routines more convenient,” a company official said. “We also offer high-performance devices at more accessible price points.”

APR’s fully integrated value chain, encompassing everything from product planning and research and development to manufacturing and distribution, has also been instrumental in enabling the company to adapt quickly to evolving market dynamics.

The company plans to debut a new lineup of modular skin care devices at CES 2026, featuring interchangeable heads that combine multiple functions in one system.

Rising demand for beauty devices has intensified competition across related industries, from cosmetics to pharmaceuticals.

Amorepacific, for instance, is doubling down on its makeON device line, launching a micro-LED mask in November that the company said increased elastin production in the skin’s deeper layers.

LG Household & Health Care is leveraging its electronics expertise under the beauty device brand LG Pra.L, while Kolmar Korea earned a CES 2026 Innovation Award in digital health for its scar-treatment device.

Smaller but influential players such as d’Alba Global are also edging into beauty devices. “We have only just begun selling our first device in the United States and Japan,” an official from d’Alba Global said, adding that the company seeks to broaden its beauty device lineup and sales network.

“Although we are still in the early stages of our beauty device business, we plan to launch an upgraded energy-based lifting device by next summer,” the official added.

With deep roots in dermatology and regenerative medicine, pharmaceutical and biotech companies benefit by applying their strengths to high-performance beauty devices.

PharmaResearch, a local biopharmaceutical company, saw sales of its Rejulift device lineup climb to 14.3 billion won in 2025, up 40% on-year. — The Korea Herald/ANN

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

House plan sets tax harbour for some stablecoins
Oil advances as US tightens Venezuela blockade
Call to rebuild fiscal buffers
Fitch pushes Gabon’s rating deeper into junk
Store expansion, earnings growth to underpin MyNews positive outlook
Fifth straight week of buying by local institutions
George Kent wins RM34.5mil LRT contract
Swiss court to hear landmark climate case against cement giant
Uber, Baidu to start joint UK robotaxi trials
Paramount eyes 10% ROE on asset optimisation

Others Also Read